💊 Bayer’s $1.4 billion Leap; Dr Reddy’s and German cannabis; Bharat Biotech to upgrade plants

Apr 04, 2022

∙ Paid

Hello and welcome back to the week. Have you met XE yet? The UK has. So has Thailand. Coming soon to a lab near you.

In today’s very short Kable: The WHO suspends Covaxin supply; Japan gets a new R&D body; Dr. Reddy’s gets a heart biz; Bayer reloads Leaps; And a peanut allergy vaccine gets manufacturing digs.

💊 Bayer’s $1.4 billion Leap; Dr Reddy’s and German cannabis; Bharat Biotech to upgrade plants

This post is for paid subscribers